BioVersys

is a Switzerland-based clinical-stage biopharmaceutical company that develops small-molecule therapeutics for the treatment of nosocomial infections...
Read more
BioVersys Founder & CEO: Marc Gitzinger

Founder & CEO

Marc Gitzinger

CEO Approval Rating

89/100

Annual Revenue
<$1M
Employees
<10
Funding
$133.5M

BioVersys Competitors

1Debiopharm
2GlycoVaxyn
3Prokaryotics
4Tetraphase
5Spero Therapeutics
6Nabriva
7Entasis
8Armata
9PharmaBiome
10Allecra Therapeutics

Trending Companies